There are always patent lawsuits and challenges happening around the country. But the new trend in patent suits — from major, established drug companies to fly-by-night outfits alike — seems to be an attempt to get a leg up by using tribal sovereignty to avoid certain parts of the process. [More]
allergan
Pfizer, Allergan Call Off $160B Mega-Merger
By 4.6.16
Five months after Pfizer and Allergan announced they would combine households to create the world’s largest drug company, the betrothed say the wedding is being called off. [More]
Feds Say Drug Company Illegally Blocked Lower-Cost Generics From Entering Market
By 3.31.16
When a drug patent nears its end, drug companies sometimes do really stupid, potentially illegal things to delay or prevent their bottom line being dinged by a lower-cost generic version. One drug company is accused of not just paying off a generic drug maker to delay the release of its version of two medications, but further hurting consumers by agreeing to not compete with the generic. [More]
Pfizer To Buy Allergan For $160B, Create World’s Largest Drug Company
By 11.23.15
If the giant pharmaceutical companies of the world seem quite big enough to you already, well, that just means you probably aren’t a major investor in or CEO of one. But the major investors and CEOs do think bigger is better, and so to that end two of them are merging to create an even bigger drug behemoth and take it overseas. [More]
FDA Approves Lap-Band Surgery For Not-As-Obese Patients
By 2.17.11
The folks at Allergan, the company behind the popular Lap-Band weight loss surgery, have 26 million reasons to cheer today. After all, that’s the number of potential new Lap-Band patients now that the FDA has lowered the minimum weight loss requirements for the procedure. [More]
Brooke Shields Has Hypotrichosis
By 10.27.09
Oh no! Brooke Shields used to have stringy, stick-figure eyelashes! I figured this out after watching Consumer Reports’ video dissection of a new commercial for Latisse, the glaucoma medication that has been rebranded as an expensive, temporary eyelash enhancer with side effects.
New York Times Calls Botox "The Duct Tape Of Medicine"
By 4.13.09
Who knew botulism could be so awesome? Botox is Allergan’s cash cow, earning the pharmaceutical company $1.3 billion last year alone. The funny thing about the toxin—originally developed as a biological weapon—is it works for a lot of “off-label” uses as well (like treating anal fissures and preventing hair loss), and Allergan says that non-cosmetic applications could be an even bigger market because health insurers will help pay for the treatments. Likely upcoming FDA-approved treatments: stroke-induced muscle spasms, chronic migraines, and enlarged prostates.
